Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

GEOPEN

CARBENICILLIN DISODIUM

Standard Dose
EQ 2GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview GEOPEN is listed in Drugs@FDA under application 050306 (NDA).

Marketing status: Discontinued Active ingredient CARBENICILLIN DISODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Sponsor ROERIG Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview GEOPEN is listed in Drugs@FDA under application 050306 (NDA). Marketing status: Discontinued Active ingredient CARBENICILLIN DISODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Sponsor ROERIG Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.